Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(25 sites)
United States
Mayo Clinic, Phoenix, Arizona Sarah Cannon Research Institute (SCRI) - HealthONE Location, Denver, Colorado Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree, Colorado Mayo Clinic, Jacksonville, Florida Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida